Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Novel methods for improved breast cancer survival

22.02.2011
A quarter of all women who suffer from breast cancer are at risk of metastasis – a recurrence of the cancer.

In recent years, researchers at Lund University, Sweden, have developed a technique that can identify in advance which patients belong to this risk group. Within the next two years the method will be tested in Swedish hospitals. In the future, the technique may also be used in hospitals in other countries.

This, together with other research within the Breast Cancer Initiative, as the project is called, has been awarded SEK 25 million from the Swedish innovation agency Vinnova. The project is part of the interdisciplinary cancer centre Create Health, where immunologists, tumour biologists, nanotechnologists, bioinformaticians and cancer researchers work together.

“This campaign means that our research can benefit patients earlier”, comments Carl Borrebaeck, Professor of Immunotechnology at Lund University and programme director for Create Health.

He and his colleagues aim to significantly shorten the waiting times for test results and information about continued treatment. The idea is to build a diagnostic clinic next to the operating theatre. The tumour can then be analysed while the patient is still on the operating table and the surgeon, oncologist and pathologist can together make a diagnosis and decide on the right treatment.

The research is based on a unique technique developed by the researchers in Lund. By analysing patterns of biomarkers, or protein molecules, in the blood, it is possible to obtain information about what type of cancer the patient has and what the prognosis is.

“We also map the tumour cells’ genome. Using this map, we can find out how responses to different types of treatment may relate to specific genes. This knowledge could be of great help in selecting the right treatment”, says Carl Borrebaeck.

The Create Health group is also in the process of developing a breast cancer index. Blood and tissue samples from patients with breast tumours are analysed on both protein and gene level and a unique ‘fingerprint’ of each tumour is obtained.

“Our aim is to analyse all the tumours in southern Sweden. This collection of samples also improves the collaboration between clinicians and researchers, as well as the chances to be able to quickly implement our research results in a clinical setting”, emphasises Carsten Rose, Professor of Oncology and head of division at Skåne University Hospital.

When it comes to the work on early identification of which patients are at risk of metastasis, the research has come a long way and has now entered its final stage.

“Currently, all women receive the same harsh treatment. However, with our technique it is possible to select which patients actually need it, and therefore also which only need a significantly milder treatment. The improved prognosis can reduce side-effects and unnecessary suffering for the patient, as well as saving a lot of money”, says Carsten Rose.

The Breast Cancer Initiative is part of Create Health, which comprises projects run by professors Åke Borg (oncology), Peter James (proteomics), Carl Borrebaeck (cancer immunology) and Carsten Rose (oncology).

For more information, please contact Carl Borrebaeck, Professor of Immunotechnology at Lund University, +46 46 222 96 13, +46 708 21 83 30, Carl.Borrebaeck@rektor.lu.se; Carsten Rose, Professor of Oncology and head of division at Skåne University Hospital, +46 46 17 69 20, +46 702 577509, Carsten.Rose@skane.se; Åke Borg, Professor of Oncology at Lund University, +46 46 177502, Ake.Borg@med.lu.se; Peter James, Professor of Proteomics at Lund University, +46 46 222 1496, +46 702 477960, Peter.James@immun.lth.se.

Megan Grindlay | idw
Further information:
http://www.createhealth.lth.se

More articles from Health and Medicine:

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

nachricht New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

Unraveling the nature of 'whistlers' from space in the lab

15.08.2018 | Physics and Astronomy

Diving robots find Antarctic winter seas exhale surprising amounts of carbon dioxide

15.08.2018 | Earth Sciences

Early opaque universe linked to galaxy scarcity

15.08.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>